|
|
 |
|
|
INDUSTRY NEWS
Clavis Pharma and Clovis Oncology Extend Partnership and Sign New $205 Million Deal for the Development and Commercialization of Anti-Cancer Agent CP-4126 in Asia and Rest of the World
Clavis Pharma ASA and Clovis Oncology, Inc. announced a new agreement for the further development and commercialization of CP-4126 (also known as CO-101), which is currently in Phase II development in pancreatic cancer. [Clavis Pharma Press Release]
London Genetics and Astrimmune to Find Predictive Biomarkers for Pancreatic Cancer Vaccine
London Genetics and Astrimmune will work together to establish a biomarker identification program for the latter's pancreatic cancer vaccine candidate. [Genetic Engineering and Biotechnology News]
Bristol-Myers Squibb Foundation Launches $100 Million Initiative Targeting America's Type 2 Diabetes Crisis
The Bristol-Myers Squibb Foundation announced Together on Diabetes®: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office -- in their homes and communities -- and for the course of their disease. [Bristol-Myers Squibb Foundation Press Release]
Xoma Issued Two New U.S. Patents Covering XOMA 052
Xoma Ltd. announced that the U.S. Patent and Trademark Office issued two new patents to Xoma as part of the company's expanding intellectual property portfolio around its XOMA 052 antibody to interleukin-1 beta. [Xoma Ltd. Press Release]
Access Pharmaceuticals Presents CobOral™ Insulin Research at 10th Annual Diabetes Technology Meeting
Access Pharmaceuticals, Inc. announced that it presented a poster at the 10th Annual Diabetes Technology Meeting, entitled, "Preclinical Studies with Cobalamin™ Nanoparticles for Oral Drug Delivery of Insulin." [Access Pharmaceuticals, Inc. Press Release]
Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting
Scientists from Biodel Inc. reported new findings from the company's Linjeta™, insulin glargine, "smart" basal insulin and stabilized glucagon development programs in poster presentations at the 10th Annual Diabetes Technology Meeting in Bethesda, MD. [Biodel Inc. Press Release]
Halozyme's rHuPH20 with Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
Halozyme Therapeutics, Inc. announced Phase II results demonstrating that Insulin-PH20 (recombinant human insulin with rHuPH20) produced glycemic control comparable to lispro. [Halozyme Therapeutics, Inc. Press Release]
Biomedical Warp Knit Project Aids Diabetes Research
Narrow fabrics machinery manufacturer Comez has developed an innovative electronic double needle bar warp knitting machine for use in an Italian regional government funded biomedical textiles project. The Panagenesi project aims to help cure diabetes by optimizing the implanting of human pancreatic islands through the use of fibrin scaffold to aid in the success of pancreatic transplants. [Knitting Industry]
Boston Scientific Announces Sponsorship of World Diabetes Day Campaign 2010
Boston Scientific Corporation announced its sponsorship of "World Diabetes Day" for the third year in a row. The campaign is led by the International Diabetes Federation and represents its primary global awareness initiative in the fight against diabetes. [Boston Scientific Corporation Press Release]
|
|
EVENTS (Listed by Date)
Pharmacology in Stem Cells Research and Regenerative Medicine
December 17, 2010
London, United Kingdom
NEW The 3rd Guangzhou International Conference on Stem Cell Biology and Regenerative Medicine
December 17-19, 2010
Guangzhou, China
Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction
January 12-17, 2011
Dillon, United States
Keystone Symposia: Obesity
January 12-17, 2011
Keystone, United States
2011 Gastrointestinal Cancers Symposium
January 20-22, 2011
San Francisco, United States
Keystone Symposia: Epithelial Plasticity and Epithelial to Mesenchymal Transition
January 21-26, 2011
Vancouver, Canada
5th Annual Stem Cells and Regenerative Medicine World Congress
January 24-25, 2011
San Diego, United States
Phacilitate 7th Annual Cell & Gene Therapy Forum 2011
January 24-26, 2011
Washington, D.C., United States
Early Development for Innovative Diabetes & Metabolic Syndrome Therapeutics Conference
January 26-27, 2011
Amsterdam, The Netherlands
Joint Conference of the International Association of Pancreatology and the Indian Pancreas Club
February 10-13, 2011
Maradu, India
NEW 2nd Annual International Diabetes Summit
February 22-24, 2011
Dubai, United Arab Emirates
United Kingdom National Stem Cell Network 2011 Annual Scientific Conference
March 30-April 1, 2011
York, United Kingdom
American Association for Cancer Research (AACR) 102nd Annual Meeting 2011
April 2-6, 2011
Orlando, United States
13th Annual C21 BioVentures
May 24-26, 2011
Napa, United States
European Pancreatic Club Meeting 2011
June 22-25, 2011
Magdeburg, Germany
PancreasFest 2011
July 28-30, 2011
Pittsburgh, United States
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES
Lab Technologist - Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies)
Lab Technologist - Tissue Culture (STEMCELL Technologies)
Product Manager - Pluripotent Stem Cells (STEMCELL Technologies)
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News at no cost.
Visit here to post your career opportunities.
Have we missed an important article or publication in Pancreatic Cell News? Click here to submit!
|
|
|
|
|
|
|
|
|
